Medartis Holding AG (XSWX:MED) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
Medartis Holding AG Forward PE Ratio Related Terms
Medartis Holding AG Forward PE Ratio Historical Data
* Premium members only.
The historical data trend for Medartis Holding AG's Forward PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medartis Holding AG Forward PE Ratio Chart
Medartis Holding AG Annual Data
Trend
2021-12
2022-12
2023-12
2024-12
2025-12
Forward PE Ratio
98.04
277.78
138.89
59.96
54.43
Medartis Holding AG Semi-Annual Data
2021-06
2021-12
2022-06
2022-12
2023-06
2023-12
2024-12
2025-06
2025-12
Forward PE Ratio
142.86
98.04
555.56
277.78
217.39
138.89
59.96
63.15
54.43
XSWX:MED vs ABT, SYK, MDT: Forward PE Ratio Comparison
For the Medical Devices subindustry, Medartis Holding AG's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medartis Holding AG Forward PE Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medartis Holding AG's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where Medartis Holding AG's Forward PE Ratio falls into.
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
Medartis Holding AG (XSWX:MED) has a Forward PE Ratio of 64.54 as of Jul. 09, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Medartis Holding AG and its competitors. According to the industry distribution chart, Medartis Holding AG ranks #341 out of 392 companies in the Medical Devices & Instruments industry, placing it in the top 87%.
Is Medartis Holding AG's Forward PE Ratio too high?
Medartis Holding AG's current Forward PE Ratio is 64.54. The Medical Devices & Instruments industry median Forward PE Ratio is 19.00. Medartis Holding AG's value of 64.54 is 239.8% above this industry median. Based on the distribution chart, Medartis Holding AG ranks #341 out of 392 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Medartis Holding AG has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medartis Holding AG's Forward PE Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medartis Holding AG ranks #341 out of 392 companies for Forward PE Ratio. This places Medartis Holding AG in the lower half of its industry. The industry median Forward PE Ratio is 19.00. Medartis Holding AG's value of 64.54 is 239.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Medical Devices & Instruments company?
The median Forward PE Ratio among Medical Devices & Instruments companies is 19.00, based on 392 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medartis Holding AG's current Forward PE Ratio of 64.54 is 239.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Medartis Holding AG and its competitors. For the Medical Devices & Instruments industry, the median Forward PE Ratio is 19.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medartis Holding AG's current Forward PE Ratio is 64.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medartis Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Medartis Holding AG (XSWX:MED) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF106.84, compared to a current price of CHF91.70 — trading 14.2% below its estimated fair value. The current Forward PE Ratio is 64.54 and 239.8% above the Medical Devices & Instruments industry median of 19.00. Medartis Holding AG's overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Medartis Holding AG (XSWX:MED), the current Forward PE Ratio is 64.54 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medartis Holding AG (XSWX:MED) Overvalued in 2026?
Based on GuruFocus' analysis, Medartis Holding AG stock appears to be undervalued.
The current stock price of CHF91.70 is trading 14.2% below its estimated GF Value™ of CHF106.84.
GuruFocus considers Medartis Holding AG to be Modestly Undervalued.
Key valuation signals for XSWX:MED:
Forward PE Ratio: 64.54
GF Value™: CHF106.84 vs. price of CHF91.70 (14.2% below fair value)
Industry Position: 239.8% above the Medical Devices & Instruments median (#341 of 392)
No single metric tells the full story. See the XSWX:MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medartis Holding AG is a medical device company. The company's product profile is divided into APTUS products, StealthFix Products, and MODUS products. APTUS includes products for the Hand, Wrist, Elbow, Shoulder, and Foot. MODUS comprises products for the mandible. Geographically, it derives the majority of its revenue from Europe, Middle East and Africa (EMEA) and also has a presence in North America, Asia Pacific, and Latin America.
85GF Score
Get the complete analysis for XSWX:MED
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:MED has been successfully added to your 